Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (TH2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from TH2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.

Original languageEnglish
Pages (from-to)29-36
Number of pages8
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume73
Issue number1
DOIs
Publication statusPublished - Jan 2018

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis'. Together they form a unique fingerprint.

  • Cite this